Legacy Trust’s Verrica Pharmaceuticals VRCA Stock Holding History

Legacy Trust’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$55.6K	Hold	16,584	–	–	0.01%	219
2026 Q2	$101K	Sell	16,584 -650	-4%	-$4.05K	0.02%	209
2026 Q1	$91.2K	Hold	17,234	–	–	0.02%	202
2025 Q4	$143K	Buy	+17,234	New	+$95.5K	0.03%	191
2025 Q3	–	Sell	-650	Closed	-$3.45K	–	190
2025 Q2	$3.45K	Hold	650	–	–	﹤0.01%	144
2025 Q1	$2.87K	Hold	650	–	–	﹤0.01%	159
2024 Q4	$4.55K	Buy	+650	New	+$7.14K	﹤0.01%	157
2024 Q2	–	Sell	-1,875	Closed	-$111K	–	150
2024 Q1	$111K	Hold	1,875	–	–	0.03%	149
2023 Q4	$137K	Hold	1,875	–	–	0.04%	155
2023 Q3	$72.8K	Hold	1,875	–	–	0.02%	156
2023 Q2	$108K	Hold	1,875	–	–	0.03%	161
2023 Q1	$122K	Buy	+1,875	New	+$113K	0.04%	157

Other funds holding VRCA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

Salomon & Ludwin Richmond, Virginia $1.21B AUM 12.69% 1-Year Est. Return

New England Capital Financial Advisors Meriden, Connecticut $430M AUM 7.57% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Valley National Advisers Bethlehem, Pennsylvania $909M AUM 22.39% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Legacy Trust's VRCA Position: Q3 2026 in Review

Legacy Trust held its Verrica Pharmaceuticals (VRCA) position steady in Q3 2026 at 16,584 shares worth $55.6K. The position accounts for 0.01% of the portfolio, ranked #219.

Legacy Trust first reported a position in VRCA in Q1 2023 and has held it in 12 quarters since. The position peaked at $143K in Q4 2025. 10 funds tracked by Wall St. Rank hold VRCA as of Q3 2026.

Legacy Trust held 16,584 shares of Verrica Pharmaceuticals worth $55.6K as of Q3 2026.
Legacy Trust left its Verrica Pharmaceuticals share count unchanged in Q3 2026.
Verrica Pharmaceuticals made up 0.01% of Legacy Trust's portfolio in Q3 2026, its #219 holding.
Legacy Trust first reported a position in Verrica Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
Legacy Trust's Verrica Pharmaceuticals position peaked at $143K in Q4 2025.
10 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2026.

Based on Legacy Trust's 13F filing for Q3 2026, filed 6 Nov 2026.